CLIFUTINIB
UNII 3BHA83P7NZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Clifutinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3BHA83P7NZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1862226-99-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
3BHA83P7NZ
CAS Registry Number
1862226-99-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CLIFUTINIB
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C29H34N4O4
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
DWZXYPARIPYQKS-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
INN ID
13852
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
N(C(Nc1ccc(C#Cc2ccc(OCCCN3CCOCC3)cc2)cc1)=O)c4cc(C(C)(C)C)on4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Clifutinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CLIFUTINIB

Common Names & Synonyms

CLIFUTINIB [INN]

Systematic Nomenclature

N-(5-(1,1-DIMETHYLETHYL)-3-ISOXAZOLYL)-N'-(4-(2-(4-(3-(4-MORPHOLINYL)PROPOXY)PHENYL)ETHYNYL)PHENYL)UREA
N-(5-TERT-BUTYL-1,2-OXAZOL-3-YL)-N'-(4-((4-(3-(MORPHOLIN-4-YL)PROPOXY)PHENYL)ETHYNYL)PHENYL)UREA
UREA, N-(5-(1,1-DIMETHYLETHYL)-3-ISOXAZOLYL)-N'-(4-(2-(4-(3-(4-MORPHOLINYL)PROPOXY)PHENYL)ETHYNYL)PHENYL)-